LOS ANGELES AND IRVINE – July 15, 2020 – ManifestSeven (“M7” or “the Company”) today announced that it has received conditional approval for the listing of its common shares on the Canadian Securities Exchange (“CSE”). Subject to satisfying customary listing obligations, the Company’s common shares will commence trading on the CSE under the ticker symbol “MSVN”.

“This is a watershed moment for ManifestSeven, our shareholders and our employees, who’ve been instrumental in helping us achieve this long-term strategic ambition,” said Sturges Karban, M7’s Chief Executive Officer. “Our company has also proven its resilience by weathering the economic impacts of COVID-19, and we’re grateful for the ongoing support of both the investment community and CSE who continue to embrace M7’s capabilities.”

The CSE has also expressed its excitement at M7’s upcoming public offering.

“The CSE is proud to welcome ManifestSeven to our publicly-listed, cannabis sector peer group on the Exchange for Entrepreneurs,” said James Black, The CSE’s Vice President of Listings Development. We are looking forward to collaborating with the company as it deploys its unique supply chain management solutions across the cannabis industry – a foundational segment of the Canadian Securities Exchange.”

ABOUT MANIFESTSEVEN:

ManifestSeven is the first integrated omnichannel platform for legal cannabis, merging compliant distribution with a retail superhighway. M7, with offices in Commerce and Irvine, California, services the needs of lawful operators across the supply chain, from the cultivator to the consumer, through an expansive network of four facilities stretching from the San Francisco Bay Area to San Diego. M7 further augments its business-to-business value proposition with a growing portfolio of owned and operated retail operations located in major metro markets, including brick-and-mortar dispensaries, local on-demand delivery services, e-commerce, and subscription offerings.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION AND STATEMENTS:

This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs and assumptions regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. This forward-looking information is based on certain assumptions made by management and other factors used by management in developing such information. Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf are expressly qualified in its entirety by this notice.

MEDIA CONTACTS:

Joel Labi, ManifestSeven

+1 (917) 415-5666

[email protected]

Dan Margolis, for ManifestSeven

+1 (213) 452-6472

[email protected]

INVESTOR RELATIONS CONTACT:

+1 (949) 409-9330

[email protected]